Onyx Pharmaceuticals




News and Media        
Onyx Pharmaceuticals

PRESS RELEASES
--------
Press Releases

To Onyx's knowledge, all press releases, scientific papers, and abstracts and the information contained within them were timely and accurate when issued. The continued accuracy of this material beyond the date of issuance and posting on the website is not assured. Onyx has no intention of updating this information, and specifically disclaims any duty to do so. These documents may contain forward-looking statements. Actual results could vary dramatically as a result of known and unknown risks and uncertainties. Please see Terms of Use for this website.

Email Alerts

Sign up here to receive press releases via email.
  Submit



  • Nov. 19, 2007
Nexavar First FDA-Approved Drug Therapy for Liver Cancer
  • Nov. 06, 2007
Onyx Pharmaceuticals Reports Third Quarter and Nine-Month 2007 Financial Results
  • Oct. 30, 2007
Nexavar Becomes First and Only Approved Treatment of Hepatocellular Carcinoma in Europe
  • Oct. 25, 2007
Onyx Pharmaceuticals Announces Third Quarter 2007 Financial Results Teleconference and Webcast
  • Oct. 04, 2007
Onyx Pharmaceuticals Announces Management Changes
  • Oct. 03, 2007
Onyx Pharmaceuticals To Present At Biotechnology Industry Organization Investor Forum
  • Sep. 21, 2007
Nexavar Receives Positive Opinion from European Committee for Medicinal Products for Human Use for Treatment of Liver Cancer
  • Sep. 18, 2007
Onyx Pharmaceuticals To Present At UBS Global Life Sciences Conference
  • Aug. 27, 2007
Nexavar Significantly Improved Overall Survival in Phase 3 Asia-Pacific Liver Cancer Trial
  • Aug. 20, 2007
Nexavar Granted FDA Priority Review for Treatment of Liver Cancer
  • Aug. 07, 2007
Onyx Pharmaceuticals Reports Second Quarter And Six-Month 2007 Financial Results
  • Jul. 31, 2007
Onyx Pharmaceuticals Announces Second Quarter 2007 Financial Results Teleconference and Webcast
  • Jun. 27, 2007
Bayer and Onyx Submit Supplemental New Drug Application for Nexavar to Treat Liver Cancer
  • Jun. 21, 2007
Onyx Announces Pricing of Public Offering
  • Jun. 19, 2007
Bayer and Onyx Submit New European Marketing Authorization Application to EMEA for Nexavar to Treat Liver Cancer
  • Jun. 18, 2007
Onyx Announces Proposed Public Offering of Common Stock
  • Jun. 04, 2007
Nexavar Significantly Extends Overall Survival by 44% in Liver Cancer Patients
  • May 25, 2007
Onyx Pharmaceuticals Announces An Analyst Briefing
  • May 23, 2007
Onyx Pharmaceuticals To Present At Bank Of America 2007 Health Care Conference
  • May 09, 2007
Onyx Pharmaceuticals Reports First Quarter 2007 Financial Results
  • May 02, 2007
Onyx Pharmaceuticals Announces First Quarter 2007 Financial Results Teleconference And Webcast
  • Apr. 27, 2007
Onyx Pharmaceuticals To Present At Morgan Stanley Global Healthcare Unplugged Conference
  • Mar. 15, 2007
Onyx Pharmaceuticals To Present At Lehman Global Healthcare Conference
  • Mar. 08, 2007
Onyx Pharmaceuticals To Present At Cowen Health Care Conference
  • Feb. 15, 2007
Onyx Pharmaceuticals Reports Fourth Quarter And Year-End 2006 Financial Results
  • Feb. 12, 2007
Onyx Pharmaceuticals Announces A Teleconference And Webcast To Provide An Update On Nexavar
  • Feb. 12, 2007
Nexavar Shown to Significantly Extend Survival for Patients with Advanced Liver Cancer
  • Feb. 09, 2007
Onyx Pharmaceuticals to Present at BIO CEO and Investor Conference
  • Feb. 08, 2007
Onyx Pharmaceuticals Announces Fourth Quarter and Year-End 2006 Financial Results Teleconference and Webcast
  • Feb. 01, 2007
Onyx Pharmaceuticals To Present At Merrill Lynch Conference
  • Jan. 24, 2007
Onyx Pharmaceuticals To Present At Wachovia Small And Mid-Cap Conference
  • Jan. 10, 2007
Bayer and Onyx Announce Pivotal Nexavar® Kidney Cancer Study Published in New England Journal of Medicine
  • Jan. 02, 2007
Onyx Pharmaceuticals To Present At JPMorgan Healthcare Conference




--------

©2009 Onyx Pharmaceuticals, Inc.